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Abstract 
S-acylation is a major post-translational modification, catalysed by the zDHHC enzyme family. S-acylated proteins can be 
modified by different fatty acids; however, very little is known about how zDHHC enzymes contribute to acyl chain 
heterogeneity. Here, we employed fatty acid azide/alkyne labelling of mammalian cells, showing their transformation into acyl-
CoAs and subsequent click chemistry-based detection, to demonstrate that zDHHC enzymes have marked differences in their 
fatty acid selectivity. This was apparent even for highly related enzymes such as zDHHC3 and zDHHC7, which displayed a marked 
difference in ability to use C18:0 acyl-CoA as a substrate. Furthermore, we identified Isoleucine-182 in the third transmembrane 
domain of zDHHC3 as a key determinant limiting the use of longer chain acyl-CoAs by this enzyme. This is the first study to 
uncover differences in the fatty acid selectivity profiles of cellular zDHHC enzymes and to map molecular determinants governing 
this selectivity.  
 
Significance Statement 
S-acylation, the attachment of different fatty acids onto cysteine residues, regulates the activity of a diverse array of 
cellular proteins. This reversible post-translational modification is essential for normal physiology and defects are linked 
to human disease. S-acylation is catalysed by a large family of “zDHHC” S-acyltransferases that use a cellular pool of 
diverse fatty acyl-CoAs as substrates. Using chemically-synthesised probes, we show that individual zDHHC enzymes 
have marked differences in fatty acid selectivity, and identify the underlying molecular basis for this. The study describes 
how acyl chain heterogeneity of S-acylated proteins is generated, and is significant because the chemical nature of the 
attached S-acyl chain can fundamentally impact protein behaviour. 
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Introduction 
S-acylation is a reversible post-translational modification 
(PTM) involving the attachment of fatty acids onto cysteine 
residues(1, 2). This PTM occurs on both soluble and 
transmembrane (TM) proteins and exerts a number of 
important effects, such as mediating membrane binding (of 
soluble proteins or soluble loops of TM proteins), regulating 
protein trafficking and targeting to cholesterol-rich 
membrane micro-domains, and modulating protein 
stability(3, 4). These actions of S-acylation on a diverse array 
of cellular proteins impact on many important physiological 
processes, and defects in this process are linked to a number 
of major diseases and disorders(2, 5). 
S-Acylation is mediated by the opposing actions of 
acyltransferases and thioesterases. S-Acyltransferase 
enzymes belong to the zDHHC protein family, which are 
encoded by twenty-four distinct genes(6-8). zDHHC enzymes 
are thought to share the same overall membrane topology, 
with 4-6 transmembrane domains and the N- and C-termini 
present in the cytosol(9). The catalytic DHHC cysteine-rich 
domain (CRD) of the enzymes lies in a cytosolic loop(9) 
allowing zDHHC enzymes to modify substrate cysteines 
present at the cytosol-membrane interface. The S-acylation 
reaction is thought to proceed through an enzyme-acyl 
intermediate, where the acyl chain is attached to the cysteine 
of the DHHC motif via a thioester linkage (often referred to as 
enzyme “autoacylation”)(10, 11). The S-acyl chain is then 
transferred to a cysteine residue of a substrate protein(10, 
11). This overall process is referred to as a “ping-pong” 
reaction mechanism. There has been progress identifying the 
zDHHC enzymes that are active against many substrate 
proteins(2), although we lack a detailed understanding of the 
protein substrate profiles of individual enzymes and how 
enzyme-substrate interaction specificity is achieved. Co-
expression experiments have suggested that individual 
zDHHC enzymes might exhibit a level of overlap in their 
protein substrate profiles, suggesting some possible 
redundancy within the zDHHC family. Nevertheless, individual 
enzymes have been linked with many disorders, including 
schizophrenia, intellectual disability, diabetes and cancer, 
suggesting that any functional redundancy is limited(2). 
In contrast to the steadily increasing knowledge about the 
specific interactions of individual zDHHC enzymes with their 
protein substrates, we know relatively little about the fatty 
acid selectivity of these enzymes. The term palmitoylation is 
often used as a synonym for S-acylation. However this does 
not reflect the potential diversity of S-acyl chains added to 
substrate proteins. Indeed, an analysis of the acyl groups 
added to S-acylated proteins in platelets revealed that 74% 
were from palmitate (C16:0), 22% from stearate (C18:0) and 
4% from oleate (C18:1)(12). Other studies have shown that S-
acylated proteins can be modified by acyl chains from 
myristic acid (C14:0), palmitoleic acid (C16:1), linoleic acid 
(C18:2) and arachidonic acid (C20:4)(12-15). Furthermore, 
mass spectrometry analysis of the S-acyl chains attached to 
influenza haemagglutinin proteins has revealed that C16:0 
and C18:0 fatty acids are attached in a site-specific 
manner(16). There is also potential for cell type specific 
differences in the fatty acid profiles of S-acylated proteins; for 
example, one study reported that in RAW26.7 cells less than 
10% of the acyl-CoAs were greater than C20, whereas in 
MCF7 cells C24:0 and C26:0 acyl-CoAs were present at similar 
amounts to C16:0 and C18:0 acyl-CoAs(17). The identity of 
the added acyl chain is central to the regulatory effects of S-
acylation as different acyl chains vary in affinity for 
membranes and for cholesterol-rich membrane micro-
domains(18). 
To-date, a single study has explored the potential role of 
zDHHC enzymes in differential protein S-acylation using 
purified recombinant zDHHC enzymes in detergent 
micelles(10). This study reported that zDHHC2 catalysed the 
S-acylation of substrate proteins with similar efficiency using 
palmitate (C16:0), stearate (C18:0) or C20 (C20:0, C20:4) fatty 
acids. In contrast, zDHHC3 displayed a marked preference for 
shorter chain length acyl-CoAs and incorporated C16:0 much 
more efficiently than either C18:0 or C20 fatty acids(10). This 
elegant study highlighted the potential for discrete patterns 
of fatty acid selectivity in the zDHHC family, but these 
questions have been challenging to address, particularly in a 
cellular context. However, recent developments at the 
chemistry-biology interface have identified new approaches 
to investigate this poorly defined area of the S-acylation field. 
Specifically, azide and alkyne fatty acid probes have provided 
novel and highly-sensitive chemical tools to interrogate S-
acylation by click chemistry(19-24). In this study, we report 
the use of chemically-synthesised azide and alkyne fatty acid 
probes to investigate fatty acid selectivity in the zDHHC 
enzyme family and determine the molecular mechanisms 
governing this specificity. 
 
Results 
Synthesised azide fatty acids are good mimics of 
endogenous fatty acids   
Fatty acid azide probes of different acyl chain length were 
synthesised as described in Supplementary Information. To 
assess their ability to be taken up by cells, the total fatty acid 
content of HEK293T cells treated with these synthesised 
azide fatty acids was determined (Figure 1). Untreated cells 
showed the expected range of saturated and unsaturated 
fatty acids, with C18:0 and C18:1 being the most abundant. 
Upon addition of the various azide fatty acids to the cells, it 
can clearly be seen that these were not only accumulated 
within the cells (with C16:0 and C18:0 azides being taken up 
significantly better than C14:0 and C20:0 azides), but also 
metabolised by the cells. For example the C16:0 azide was 
elongated to C18:0, which was subsequently desaturated to 
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C18:1, while the added C18:0 azide was also desaturated to 
C18:1 and to a very minor extent C18:2. However, C18:0 
azide was not significantly elongated to C20:0, and the added 
C20:0 azide was neither elongated, nor desaturated (data not 
shown). This is not surprising as the respective elongase has a 
high preference for C20:4 to C22:5 and the desaturase has a 
high selectivity for C18:0(25).  
As S-acylation of proteins involves acyl-CoA donors, it was 
deemed important that the impact on the cellular acyl-CoA 
pools be determined. This was achieved using a multiple 
reaction monitoring mass spectrometric method in 
conjunction with an internal non-natural (C17:0) acyl-CoA 
standard. This analysis revealed that in the untreated 
HEK293T cells, the C18:1- and C16:0-CoAs were the most 
abundant, accounting for almost half of the total acyl-CoA 
pool (Figure 2). Upon addition of the various azide fatty acids, 
a significant amount of the corresponding acyl-CoA azides 
were formed, including some of the corresponding 
metabolised (elongated and desaturated) acyl-CoAs azides, 
reflecting the total fatty acid content. It is interesting to note 
that there were decreases in the corresponding endogenous 
acyl-CoA pools, suggesting clear competition for the acyl-CoA 
synthases that have a preference for particular acyl chain 
length.  
Collectively, these data strongly suggest that the synthesised 
azide fatty acids are good mimics of the natural saturated 
fatty acids and can be used for downstream metabolic 
processes involving fatty acids, such as lipid metabolism and 
protein lipidation. 
 
zDHHC enzymes display marked differences in fatty acid 
azide selectivity in cell-based substrate S-acylation assays 
To test the ability of the synthesised azide fatty acid probes 
to reliably measure protein S-acylation, HEK293T cells were 
co-transfected with EGFP-SNAP25b and HA-zDHHC3 or an 
inactive mutant of this enzyme (C157S). Figure 3A shows that 
zDHHC3 promoted a marked increase in incorporation of the 
azide probes into SNAP25, whereas in the absence of active 
enzyme (either empty vector or the C157S mutant) only a low 
signal was detected, presumably representing SNAP25 that is 
modified by endogenously-expressed zDHHC enzymes. To 
test if the incorporated azide probes were attached to 
SNAP25 via thioester linkage, transfected cells were treated 
overnight with 1M hydroxylamine (HA) pH 7, which led to a 
marked loss of labelling, whereas incubation with 1M Tris (pH 
7) as a control had no effect (Figure 3B). 
The results presented in Figure 3 suggest that the level of 
C18:0 incorporation into SNAP25 by zDHHC3 is markedly 
lower than C14:0 and C16:0. Our previous work and others’ 
has shown that five zDHHC enzymes are active against 
SNAP25 in similar co-expression assays: zDHHC2, zDHHC3, 
zDHHC7, zDHHC15 and zDHHC17(26). Thus, we undertook a 
quantitative comparison of SNAP25 S-acylation by these five 
zDHHC enzymes to examine for the first time if zDHHC 
enzymes exhibit any differences in fatty acid selectivity when 
expressed in cells. The results shown in Figure 4A (top panel) 
confirm that zDHHC3 has a marked preference for 
C14:0/C16:0 over C18:0-azide. Interestingly, zDHHC7 which is 
highly related to zDHHC3 at sequence level (67.8% identical 
for mouse) incorporated C18:0-azide into SNAP25 more 
efficiently than zDHHC3 did, although there was still a 
significant reduction in C18:0 incorporation relative to 
C14:0/C16:0 with this enzyme (Figure 4A, top panel). zDHHC2 
and zDHHC15, also displayed interesting differences in fatty 
acid azide selectivity despite being highly related at amino 
acid level (65.4% identical): zDHHC2 exhibited no significant 
preference whereas C18:0 incorporation into SNAP25 by 
zDHHC15 was markedly lower than C14:0/C16:0 azides 
(Figure 4A, middle panel). Finally, zDHHC17 showed a 
preference for longer chain fatty acids and incorporated 
C16:0 and C18:0 with higher efficiency than C14:0 (Figure 4A, 
bottom panel). We also synthesised corresponding alkyne 
probe and assayed their incorporation into SNAP25 by 
zDHHC-3, -7 and -17, which revealed the same distinct 
profiles as seen with the azide probes (Figure 4B). To avoid 
confusion, the number of carbon groups given in the name 
for the alkyne probes reflects those of the fatty acid minus 
the alkyne group. Thus, C14:0-alkyne is a C14 fatty acid chain 
plus an alkyne group (16 carbon atoms total). Synthesis of 
these alkyne probes and their IUPAC nomenclature is given in 
the Supplementary Information. 
To generate a more comprehensive understanding of the 
limits of zDHHC fatty acid selectivity, we also examined C20:0 
and C22:0 azide probes. zDHHC3 showed no difference in 
ability to transfer C18:0, C20:0 or C22:0 (low incorporation 
for each), whereas zDHHC7 and zDHHC17 displayed a gradual 
decline in azide incorporation as chain length was increased 
(Figure 5A). We also used competition assays to test the 
ability of unlabelled fatty acids to block C16:0 azide 
incorporation into SNAP25 by zDHHC3 and zDHHC17. 
Consistent with the observation that zDHHC3 did not 
incorporate the C18:0 azide probe with high efficiency, 
neither stearic acid (C18:0) nor oleic acid (C18:1) could block 
incorporation of C16:0 azide into SNAP25 catalysed by this 
enzyme, whereas myristic acid (C14:0), palmitic acid (C16:0) 
and palmitoleic acid (C16:1) were all effective inhibitors 
(Figure 5B). In contrast to zDHHC3, stearic acid effectively 
blocked C16:0 azide incorporation into SNAP25 by zDHHC17, 
whereas myristic acid and palmitic acid had no significant 
inhibitory effect (Figure 5B). Furthermore, oleic acid and 
linoleic acid (C18:2) also blocked incorporation of C16:0 
azide, and indeed even arachidonic acid (C20:4) was effective 
at blocking C16:0 azide incorporation by zDHHC17 (Figure 
5B). The inhibitory effects of these longer chain unsaturated 
fatty acids are interesting given that significant amounts of 
the respective acyl CoAs are present in HEK293T cells (Figure 
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2). In contrast, lignoceric acid (C24:0) did not inhibit C16:0 
azide incorporation, consistent with the results presented in 
Figure 5A showing that C22:0 azide displayed a marked 
reduction in incorporation by zDHHC17 compared with 
shorter chain azide probes. Autoacylation of all zDHHC 
enzymes tested was dependent on an intact DHHC motif 
(Supplementary Figure 1). 
Different fatty acid selectivities of zDHHC enzymes 
corresponds to autoacylation status 
The S-acylation reaction proceeds via an enzyme-acyl 
intermediate (referred to as “autoacylation”) and is followed 
by transfer of the acyl chain to a substrate protein(10). We 
therefore tested if the different substrate S-acylation profiles 
observed in Figures 4 and 5 correspond with the 
autoacylation status of zDHHC enzymes. Figure 6A reveals 
that the autoacylation profile of zDHHC-2, -3, -7 and -15 were 
essentially identical to the profile observed for these 
enzymes with SNAP25 S-acylation (Figure 4). Despite 
repeated attempts, we were unable to reliably detect 
autoacylation of zDHHC17 and therefore could not compare 
the autoacylation profile of this enzyme with its substrate S-
acylation profile. As enzyme autoacylation reliably reports on 
fatty acid selectivity of zDHHC enzymes, we extended this 
analysis to provide a more comprehensive study of the 
zDHHC family. Further distinct fatty acid azide selectivity 
profiles were identified for a set of zDHHC enzymes for which 
autoacylation was readily detectable: zDHHC5 and zDHHC11 
exhibited a preference for C14:0/C16:0, zDHHC4 showed no 
preference for C14:0/C16:0/C18:0 and zDHHC23 displayed a 
marked preference for C18:0 over C14:0 and C16:0 (Figure 
6B). 
Differences in fatty acid selectivities of zDHHC3 and zDHHC7 
are linked to residues in the third transmembrane domain 
To understand how differences in fatty acid selectivity might 
be encoded at the molecular level, we undertook a 
systematic domain swapping analysis of zDHHC3 and 
zDHHC7. These enzymes are highly conserved and thus we 
reasoned that domain swapping between these two isoforms 
should be less likely to produce deleterious effects on protein 
folding than similar analyses of other zDHHC enzymes. 
zDHHC3 and zDHHC7 exhibited a marked difference in ability 
to incorporate the C18:0 azide probe (Figure 7A) and 
therefore we focused on this distinction between these two 
enzymes. This distinction was observed for SNAP25 S-
acylation (Figure 4), enzyme autoacylation (Figure 6), and we 
also confirmed it using a different substrate protein (cysteine-
string protein; Supplementary Figure 2a). Furthermore, 
endogenous proteins showed a similar pattern of labelling 
(Supplementary figure 2b). zDHHC3 and zDHHC7 consist of 
four predicted transmembrane domains with cytosolic N- and 
C-termini and a central intracellular loop containing the 51-
amino acid catalytic DHHC-CRD (See Figure 7B). Interestingly, 
replacing either the N- or C-terminal domain or the DHHC-
CRD of zDHHC3 with the same domains from zDHHC7 had no 
detectable effect on the fatty acid selectivity profile of 
zDHHC3 (Figure 7C). In contrast, replacing all four 
transmembrane domains of zDHHC3 with those from zDHHC7 
or only the second and third transmembrane domains 
resulted in a significant increase in C18:0 azide incorporation 
into SNAP25 by these mutant enzymes (Figure 7D), mirroring 
the fatty acid profile of zDHHC7 (see Figure 7A). Further 
analysis revealed that substituting only transmembrane 
domain three of zDHHC3 with the same domain from zDHHC7 
was sufficient to change the C18:0 selectivity profile of 
zDHHC3 (Figure 7E). 
To pinpoint the specific features of TMD3 that are important 
for dictating the fatty acid selectivity profile of zDHHC3, we 
compared the amino acid sequences of this domain from 
zDHHC3 and zDHHC7 (Figure 8A). There are four differences 
in amino acid sequence between zDHHC3 and zDHHC7 in this 
region and thus we generated two mutants containing either 
I182S/L184V or M189L/V190C mutations. Figure 8B shows 
that the I182S/L184V mutation led to a marked increase in 
C18:0 azide incorporation into SNAP25 by zDHHC3, whereas 
the M189L/V190C mutations had no effect. Thus, we 
subsequently generated single I182S and L184V mutations, 
which clearly showed that the I182S mutation in zDHHC3 
significantly enhanced the level of C18:0 incorporation by 
zDHHC3 whereas the L184V mutation had no effect (Figure 
8C). It is interesting to note that zDHHC7 in Danio rerio has an 
isoleucine rather than a serine residue at this position (see 
Figure 8A). When autoacylation profiles of zDHHC3 and 
zDHHC7 from this species were examined, we found no 
significant difference in C18:0 azide incorporation 
(Supplementary Figure 3), further supporting the important 
role played by the I/S residues in determining the fatty acid 
selectivity profiles of zDHHC enzymes. 
Finally, to exclude the possibility that any findings with the 
fatty acid azide probes were related to the presence of the 
azide/alkyne group, we examined incorporation of 3H-
palmitic acid and [3H]stearic acid into SNAP25 by zDHHC3, 
zDHHC7 and the zDHHC3 (I182S) mutant. Figure 9 shows that 
the level of incorporation of [3H]palmitic acid catalysed by 
these zDHHC enzymes was similar. In contrast, zDHHC7 more 
effectively incorporated [3H]stearic acid than zDHHC3, and 
the zDHHC3 (I182S) mutant displayed a significant increase in 
[3H]stearic acid incorporation compared with wild-type 
zDHHC3 and to a similar level as seen with zDHHC7. Thus, the 
results of these experiments fully support the results 
obtained with the fatty acid azides. 
 
Discussion 
This study provides the first analysis of zDHHC enzyme fatty 
acid selectivity within a cellular context. The only other study 
to examine how zDHHC enzymes handle acyl CoA substrates 
explored S-acylation by purified zDHHC2 and zDHHC3 in 
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detergent micelles(10). Jennings and Linder demonstrated 
that zDHHC3 has a strong preference for C16:0 over C18:0 
acyl CoA, whereas zDHHC2 displays no overt preference(10). 
Importantly, this present study has shown that these 
differences are also seen when zDHHC2 and zDHHC3 are 
expressed in mammalian cells. zDHHC3 is Golgi-localised(27), 
whereas zDHHC2 associates with the plasma membrane and 
endosomes(28). Therefore, the acyl CoA selectivity profiles of 
zDHHC2/3 are preserved irrespective of whether the enzymes 
are in detergent micelles or native membranes and 
irrespective of localisation to distinct membrane 
compartments. 
S-acylation occurs via a two-step process involving enzyme 
“autoacylation” and subsequent transfer of the acyl chain 
onto the substrate protein. zDHHC autoacylation provides a 
robust measure of fatty acid selectivity as we clearly showed 
that the autoacylation profile of zDHHC2, -3, -7 and -15 
closely matched their respective substrate S-acylation 
profiles. This allowed us to investigate the acyl CoA selectivity 
of an additional set of enzymes by measuring autoacylation 
activity. Overall, the results of this part of the study showed 
that zDHHC-3, -5, -7, -11 and -15 prefer C14/C16 over C18, 
zDHHC-2 and -4 display no clear fatty acid preference, 
zDHHC17 prefers C16/C18 over C14, and zDHHC23 exhibits a 
strong preference for C18. These observations re-emphasise 
the point made above that acyl CoA specificities do not show 
any correlation with intracellular localisation, for example, 
zDHHC-3, -7, -15, -17 and -23 all localise to the Golgi region of 
cells(27, 29), whereas zDHHC-2 and -5 are localised to the 
plasma membrane(26), and zDHHC4 is ER-localised(30). 
zDHHC-3 and -7 are highly related at the sequence level, co-
distribute on Golgi membranes and share many common 
protein substrates. Yet these enzymes have a significant 
difference in acyl CoA selectivity, with zDHHC7 having an 
increased ability to incorporate C18:0 chains relative to 
zDHHC3. The high sequence conservation of zDHHC-3 and -7 
provided an opportunity to undertake a comprehensive 
domain swapping analysis to pinpoint features that underpin 
acyl CoA selectivity. This analysis identified a single amino 
acid in the third transmembrane domain of zDHHC3 as a 
critical determinant limiting the use of longer chain fatty 
acids by this enzyme. When Ile-182 was replaced by the 
serine present at the same position in zDHHC7, a significant 
increase in the ability of the mutant protein to incorporate 
C18:0 was noted. We confirmed the importance of this 
residue using both C16:0/C18:0 azides with click chemistry 
detection and [3H]palmitic acid/stearic acid labelling. In this 
regard, it is interesting that neither the azide or alkyne group 
present on the probes appeared to influence acyl chain 
selectivity, perhaps suggesting that these chemical groups 
have a flexible character that does not impede association 
with the zDHHC enzyme. Consistent with this notion, we also 
found that the fatty acid azides selectively competed for the 
formation of endogenous acyl-CoA of the same chain length 
when added to HEK293T cells. This shows that the azide 
probes compete with and are very good mimics of 
endogenous fatty acids, and are therefore excellent chemical 
biology tools with which to interrogate aspects of fatty acid 
biology such as S-acylation.  
Although we performed a comprehensive domain-swapping 
analysis between zDHHC3 and zDHHC7, the high similarity of 
these two enzymes means that other factors that are 
important for acyl chain selectivity could have been missed 
(since these other factors could be conserved between 
zDHHC-3 and -7). Nevertheless, the approach taken here 
provides an important first step towards understanding the 
basis for acyl CoA selectivity in the zDHHC family, and clearly 
shows the importance of TMDs in this regard. Interestingly, a 
lysine was identified in the transmembrane domain of an 
elongase component of the yeast very long-chain fatty acid 
synthase complex that was also a key determinant of the final 
length of fatty acyl CoA chain synthesised by this enzyme 
complex(31). In addition, a subsequent mutational analysis of 
the related rat elongases Elovl2 and Elovl5 also highlighted 
the importance of the transmembrane domains of these 
enzymes in setting the substrate specificity profiles. Elovl2 is 
required for synthesis of omega-3 docosahexaenoic acid 
(DHA; 22:6n-3) as this elongase (but not Elovl5) can elongate 
docosapentaenoic acid (22:5n-3) to 24:5n-3, a precursor of 
DHA. This difference in substrate specificity between Elovl2 
and Elovl5 was shown to involve a region encompassing 
transmembrane domains 6 and 7, with a cysteine-to-
tryptophan switch in transmembrane domain 7 proving to be 
particularly important in setting specificity(32). 
It is tempting to speculate that the transmembrane domains 
of zDHHC enzymes form “channels” that accommodate 
specific acyl CoA molecules. This could involve different 
transmembrane domains in the same zDHHC molecule or 
might require dimerization and multimerisation of zDHHC 
enzymes(33). As isoleucine occupies more space that serine, 
it is possible that this amino acid in TMD3 of zDHHC3 limits 
the length of acyl chain that can be accommodated by 
blocking the acyl-CoA channel. This idea is consistent with the 
position of the isoleucine residue in zDHHC3, which is present 
in the middle of TMD3. Indeed, the catalytic DHHC-CRD of 
zDHHC enzymes is present immediately preceding TMD3, 
suggesting that the cysteine in the DHHC active site could be 
positioned close to the channel opening. 
Mass spectrometry-based analysis of the lipidation profile of 
haemaglutinin (HA) from influenza has shown site-specific 
attachment of palmitate or stearate chains onto this 
protein(34). Interestingly, C18:0 is added specifically to a 
cysteine present in the transmembrane domain whereas 
C16:0 is attached to cysteines in a membrane proximal 
domain. It is not clear how this highly selective process is 
achieved but our results suggest that the modified cysteines 
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in this protein might be targeted by different zDHHC enzymes 
with distinct acyl CoA specificities. It is also possible that 
there is sometimes a contribution made by the substrate in 
determining which fatty acids are attached at specific sites. 
Thus, for transmembrane proteins, S-acylated cysteines are 
often adjacent to transmembrane domains and it is possible 
that the sequence of the substrate transmembrane domain 
affects which fatty acids can be attached to the adjacent 
cysteine in a similar way as seen here for zDHHC enzymes. 
There are two major properties of S-acylation that are 
thought to be central to its various effects on modified 
proteins: increased hydrophobicity and affinity for 
cholesterol-rich membranes(3, 35). Hydrophobicity is 
fundamental to the effects of S-acylation on reversible 
membrane binding of many soluble proteins and in regulating 
the membrane association of soluble loops of 
transmembrane proteins(3). Association with cholesterol-rich 
membranes is thought to influence aspects of protein 
trafficking and membrane compartmentalisation. It is well 
established from in vitro studies that saturated phospholipids 
cluster together with cholesterol, whereas unsaturated 
phospholipids are excluded from these domains(36). 
Although the effects of saturated versus unsaturated S-acyl 
chains have not been studied in such detail, it is clear that S-
acylation is a major signal for association with cholesterol-
rich domains at least in vitro(37). It is likely that the addition 
of saturated versus unsaturated acyl chains onto proteins 
have distinct influences on membrane partitioning and 
subsequent trafficking and function in the cell. Furthermore, 
the acyl chain added to S-acylated proteins is also likely to 
affect the strength of membrane association. Although it is 
clear that two tandem lipid modifications (e.g. 
myristoylation/palmitoylation or prenylation/palmitoylation) 
provides a strong membrane anchor, a single lipid group (e.g. 
myristoyl or prenyl) is not sufficient for membrane 
association in the absence of other signals such as a polybasic 
region(38). However, single myristate (C14:0), palmitate 
(C16:0) or stearate (C18:0) groups added to an S-acylated 
protein could have markedly different effects on membrane 
association. Indeed, it was suggested that stearate has a 
significantly enhanced strength of interaction with 
phospholipid membranes compared with palmitate(12). 
 This study has identified clear differences in the fatty 
acylation profiles of different zDHHC enzymes and their 
substrates expressed in HEK293 cells. In future work it will be 
important to further advance understanding of this area and 
the functional significance of fatty acid heterogeneity by 
investigating fatty acid selectivity of endogenous proteins and 
how this is impacted by a dynamic and heterogeneous acyl 
CoA pool. The distribution of different pools of acyl-CoAs and 
their availability for use in S-acylation reactions is unclear at 
this time, and this will be an important area of future 
investigations. 
 
Materials and Methods 
Materials 
Mouse monoclonal GFP antibody was from Clontech (CA, 
USA). Rat high-affinity HA antibody was from Roche (West 
Sussex, UK). IR-dye conjugated secondary antibodies and 
alkyne/azide probes were purchased from LI-COR (Cambridge 
UK). [9,10-3H] palmitic acid and [9,10-3H] stearic acid (specific 
activity for each 1.11-2.22 TBq/mmol) were from Hartmann 
Analytic (Braunschweig, Germany). Lipofectamine 2000 was 
from Invitrogen (Paisley, UK). Oligonucleotide primers were 
purchased from Sigma (Poole, UK). 
Cell culture and transfection 
HEK293T cells (obtained from ATCC) were cultured in DMEM 
supplemented with 10% fetal bovine serum at 37 0C and in a 
humidified atmosphere containing 5% CO2. Cells were plated 
on 24-well plates and transfected the following day using 
Lipofectamine 2000 according to the manufacturer’s 
instructions. For substrate S-acylation assays, 0.8 g of EGFP-
SNAP25 were co-transfected with 1.6 g of zDHHC plasmid 
(in pEF-BOS-HA backbone). For autoacylation assays, 3 g of 
zDHHC plasmid was used. Cells were labelled and processed 
the day after transfection. 
Quantification of fatty acids and acyl-CoAs 
Cells were collected by centrifugation and washed with 
serum free DMEM, prior to incubation at 37ºC for 15 min 
with DMEM only, followed by the addition of defatted BSA 
coupled to the appropriate fatty acid azide (100 µM final 
concentration) and incubated for 4 hours at 37ºC.  Cells were 
then harvested by centrifugation and either washed in ice 
cold PBS and freeze-dried for total fatty acid determination or 
processed for acyl-CoA extraction (see below).  
For total fatty acid determination, the freeze-dried cells were 
subjected to acid hydrolysis using constant boiling HCl (6 M, 
200 μL) vortexing/sonication followed by incubation for 16 h 
at 110ºC. After cooling, the samples were spiked with 100 
pmoles of C17:0 fatty acid (as an internal control) and 
processed and derivatised to fatty acid methyl esters 
(FAMEs), prior to analysis by gas chromatography-mass 
spectrometry (GC-MS) as described previously(39). The 
individual azide fatty acids were also converted to their 
corresponding FAMEs and analysed by GC-MS to determine 
retention time and fragmentation patterns (data not shown). 
For acyl-CoA extraction and quantification, the absolute 
number of cells was determined (typically between 2-4 x 107 
cells). Cells were harvested by centrifugation at 15,000 x g for 
1 min at room temperature and the supernatant media 
removed.  The pellet was washed briefly with 200 l of ice-
cold PBS and completely lysed with ice-cold TCA (100 l, 1M) 
and vortexing, and stored on ice to prevent sample 
hydrolysis. 
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The internal standard C17:0-CoA (150 pmol) was added to the 
lysate and the sample centrifuged (15,000g, 10 min, 4C).  
The resulting supernatant was transferred to a fresh pre-
cooled tube. EDTA (25 l, 10 mM, pH 7.0) was added 
followed by chloroform (50 L) triethylammonium acetate 
(50 l), and the mixture was vortexed and centrifuged 
(15,000 x g, 10 min, 4C). The upper phase was carefully 
removed to a fresh Eppendorf tube, flash frozen in liquid 
nitrogen and freeze dried. The dried sample was kept at -
80C prior to analysis by electrospray-mass spectrometry (ES-
MS), using multiple reaction monitoring (MRM) similar to the 
method of Haynes et al(17). 
Samples were suspended in 15 μl of a 1:2 (v/v) chloroform / 
methanol and 5 μl of acetonitrile / isopropanol / water (6:7:2) 
and delivered using a NanoMate (Advion) to a AB Sciex 4000 
QTRAP triple quadrupole mass-spectrometry with a 
nanoelectrospray source, using nitrogen as the collision gas. 
A MRM approach was utilized to quantify acyl CoA. MRM 
mass transition (Supplementary Table) for the acyl-CoAs was 
determined in positive ion mode, (EP 8 eV, CXP 12 eV, an 
interface temperature of 30°C , gas pressure 0.5 psi and a tip 
voltage of 1.25-1.5kV, dwell time 500 mS), spectra were 
acquired for 2 minutes. All MRM data were normalized 
relative to the internal standard before generating standard 
curves (0.1-500 pmoles) for the acyl-CoAs (C14:0. C16:0, 
C17:0, C18:0, C20 and C20:4) which were obtained from 
either Sigma or Avanti Polar Lipids (Alabaster, AL), allowing 
their own response factor to be determined. Samples were 
analysed in the same manner, allowing quantification of the 
extracted acyl-CoAs. 
Cell labelling with fatty acid azide and alkyne probes for 
analysis of S-acylation 
HEK293T cells were incubated with 100 M of the fatty acid 
azide probes (in DMEM with 1 mg/ml defatted BSA) for 4 
hours at 37 OC. For competition experiments, transfected 
cells were labelled with 100 µM of the C16:0 azide probe in 
the presence of a 3-fold excess (300 µM) of the relevant fatty 
acid. For cell labelling with [3H]palmitic acid and [3H]stearic 
acid (Hartmann Analytic), transfected cells were incubated in 
DMEM/BSA containing 0.5 mCi/ml of the tritiated fatty acid 
probes for 4 hours at 37 OC. 
Detection of fatty acid azide and alkyne probes in S-acylated 
proteins 
Cells were washed twice in phosphate-buffered saline (PBS) 
then lysed on ice in 100 l of 50mM Tris pH 8.0 containing 
0.5% SDS and protease inhibitors (Roche, West Sussex UK). 
Conjugation of azide or alkyne IR-800 Dye (LI-COR, Cambridge 
UK) to fatty acid azide or alkyne probes was carried out for 1 
hr at room temperature with end-over-end rotation by 
adding an equal volume (100 l) of freshly mixed click 
chemistry reaction mixture containing 10 M IRDye® 800CW 
azide or alkyne Infrared Dye, 4 mM CuSO4, 400M Tris[(1-
benzyl-1H-1,2,3-triazol-4-yl)methyl]amine  and 8 mM 
ascorbic Acid in dH20. Proteins were isolated by acetone 
precipitation and resuspended in 100 l SDS sample buffer 
(50mM Tris pH 8.0, 10% glycerol, 2% SDS and 0.1% 
bromophenol blue) containing 25 mM DTT. Samples were 
incubated at 95°C for 5 minutes and 10-15 l of each sample 
was resolved electrophoretically on 12% Tris-glycine SDS-
PAGE gels.  
For detection of [3H] fatty acid probes, cell lysates were 
resolved by SDS-PAGE and transferred to duplicate 
nitrocellulose membranes. One membrane was 
immunoblotted with antibodies recognising the GFP- and HA- 
tags. The other membrane was exposed to light-sensitive film 
in the presence of a Kodak Biomax Transcreen LE intensifier 
screen for detection of [3H] fatty acid probe incorporation. 
Generation of mutant zDHHC constructs 
The zDHHC3 chimeras containing the N- and C-terminal 
domains (zDHHC3/CN7) or intracellular domain including the 
zDHHC cysteine-rich domain of zDHHC7 (zDHHC3/CRD7) were 
generated within the HA-tagged constructs by inserting Nhe1 
and Sal1 restriction sites at the boundaries of the domains 
that were swapped (upstream of C47 and F235 in zDHHC3 
and C50 and F238 in zDHHC7 for zDHHC3/CN7, and S93 and 
T176 in zDHHC3 and S96 and T179 in zDHHC7 for 
zDHHC3/CRD7) by site-directed mutagenesis. The regions 
were then swapped by restriction/ligation and the Nhe1/Sal1 
restriction sites removed using site-directed mutagenesis. 
The zDHHC3 chimeras containing the transmembrane 
domains of zDHHC7 were constructed using GeneArt gene 
synthesis services (Thermo Fisher Scientific) and sub-cloned 
into pEF-BOS-HA vector using BamH1 restrictions sites. The 
transmembrane domains predicted by UniProt were defined 
as follows: zDHHC3 A48-V68 (TMD1), Y73-S93 (TMD2), F172-
F192 (TMD3), I215-F235 (TMD4); zDHHC7 A51-L71 (TMD1), 
F76-S96 (TMD2), F175-G194 (TMD3), I218-F238 (TMD4). Site-
directed mutants were generated using PCR. The validity of 
all clones was confirmed by sequencing. 
Data Quantification and Statistical Analysis 
Quantification of all click chemistry experiments was 
performed by expressing the click signal relative to the 
corresponding protein signal (immunoblot). For substrate S-
acylation assays, this was then normalised to control (empty 
pEF-BOS-HA plasmid). Statistical analysis was performed 
using a one-way ANOVA with a Tukey post-test using 
Graphpad Prism software. 
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Figure Legends 
 
Figure 1: Relative percentage of the total fatty acid content of cells with and without treatments of azide-fatty acids. 
HEK293T cells were incubated with or without fatty acid azides. Fatty acids released from cellular lipids and protein by acid were 
then converted to methyl esters and analysed by GC-MS as described in material and methods. Values shown are means ± SEM 
(n=3). 
 
Figure 2: Quantification of the acyl-CoA content of HEK293T cells with and without treatments of azide-fatty acids. 
HEK293T cells were incubated with or without fatty acid azides and acyl-CoAs were then quantified as described in materials and 
methods. Values shown are means ± SEM (n=3). 
 
Figure 3: S-acylation of EGFP-SNAP25B by zDHHC3. 
HEK293T cells were transfected with EGFP-SNAP25b and pEF-BOS-HA (vector), HA-zDHHC3, or HA-zDHHC(C157S), or were left 
untransfected. Cells were then incubated with C14:0, C16:0 or C18:0 fatty acid azides for 4h at 37 ºC. Incorporated fatty acid azides 
were detected by click chemistry using an alkyne-800 infrared dye. Isolated proteins were resolved by SDS-PAGE and transferred to 
nitrocellulose membranes. Representative images are shown. (a) Upper panel: click chemistry signal. Middle panel: anti-GFP 
immunoblot. Lower panel: anti-HA immunoblot. Arrowheads denote the position of the EGFP-SNAP25 band (top and middle panels) 
and hA-zDHHC3 band (lower panel). (b) Following click chemistry, samples were incubated in hydroxylamine (+) or Tris (-) to a final 
concentration of 1M overnight prior to SDS-PAGE. Upper panel: click chemistry signal. Lower panel: anti-GFP immunoblot. Position 
of molecular weight markers is shown. 
 
Figure 4: S-acylation of EGFP-SNAP25B by different zDHHC enzymes. 
HEK293T cells were transfected with EGFP-SNAP25B and pEF-BOS-HA (vector), HA-zDHHC-2, -3, -7, -15 or -17. Cells were then 
incubated with C14:0, C16:0 or C18:0 fatty acid azides or alkynes as indicated for 4h at 37 ºC. Fatty acid azides/alkynes were labelled 
by click chemistry using an alkyne- or azide-800 infrared dye. Isolated proteins were then resolved by SDS-PAGE and transferred to 
nitrocellulose membranes. (a) S-acylation analysis of EGFP-SNAP25B using fatty acid-azides. Representative images are shown in the 
left panel with position of molecular mass standards indicated; graphs showing mean ± SEM shown are in the right panel. zDHHC3: n 
= 46; zDHHC7: n = 26; zDHHC2: n= 10; zDHHC15: n = 9; zDHHC17: n = 22. **p < 0.01; ***p < 0.001. (b) S-acylation analysis of EGFP-
SNAP25B in HEK293T cells labelled with fatty acid-alkynes. Graphs show mean ± SEM (n=10). ns = not significant; **p < 0.01; ***p < 
0.001. 
 
Figure 5: S-acylation of EGFP-SNAP25B by longer-chain saturated and unsaturated fatty acids.  
(a) S-acylation analysis of EGFP-SNAP25B by HA-zDHHC3, HA-zDHHC7 and HA-zDHHC17 in HEK293T cells with C14:0, C16:0, C18:0, 
C20:0 and C22:0 fatty acid-azides. Representative images are shown and position of molecular mass standards indicated. Upper 
panel: click chemistry signal. Middle panel: anti-GFP immunoblot. Lower panel: quantified data. n ≥ 3, mean ± SEM. (b) Competition 
analysis of EGFP-SNAP25b S-acylation by HA-zDHHC3 (upper panel) or HA-zDHHC17 (lower panel) in HEK293T cells labelled with 
C16:0-azide in the presence of 3-fold excess of the indicated unlabelled (u) fatty acids. Position of molecular mass standards is 
shown. Graphs show mean values ± SEM (n ≥ 3). ns = not significant; *p < 0.05; **p < 0.01; ***p < 0.001. 
 
Figure 6: Autoacylation of zDHHC enzymes by fatty-acid azides.  
HEK293T cells transfected with HA-tagged zDHHC constructs were incubated with C14:0, C16:0 or C18:0 fatty acid azides for 4h at 37 
ºC. Fatty acid azides were then labelled by click chemistry using an alkyne-800 infrared dye. Isolated proteins were resolved by SDS-
PAGE and transferred to nitrocellulose membranes.  Representative click signals and western blots with position of molecular mass 
standards indicated, together with quantified data (mean ± SEM) are shown for each zDHHC enzyme. (a) Autoacylation of zDHHC 
enzymes active against SNAP25B. zDHHC2: n = 6; zDHHC3: n = 14; zDHHC7: n = 11; zDHHC15: n = 6. (b) Autoacylation of additional 
zDHHC enzymes. n ≥ 6. ns = not significant; *p < 0.05; **p < 0.01; ***p < 0.001. The arrowhead on the zDHHC5 blot indicates the 
zDHHC5 band. 
 
Figure 7: S-acylation of EGFP-SNAP25B by zDHHC3/zDHHC7 chimeras. 
HEK293T cells were transfected with EGFP-SNAP25B and pEF-BOS-HA (vector) or the indicated wild-type or mutant zDHHC 
constructs. Cells were then incubated with C14:0, C16:0 or C18:0 fatty acid azides for 4h at 37 ºC. Fatty acid azides were labelled by 
click chemistry using an alkyne-800 infrared dye. Isolated proteins were then resolved by SDS-PAGE and transferred to nitrocellulose 
membranes for analysis. (a) Quantification of the relative levels of C14:0-, C16:0- or C18:0-azide incorporation into EGFP-SNAP25B 
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by zDHHC3 or zDHHC7 (mean ± SEM). n ≥ 26. (b) Schematic illustration detailing the zDHHC3/zDHHC7 chimeras that were 
constructed. (c-e) Analysis of EGFP-SNAP25B S-acylation by zDHHC3 chimeras with fatty acid-azides. Representative images are 
shown on the left, graphs showing mean ± SEM are on the right. (c) n ≥ 4. (d) n = 6. (e) n ≥ 12. ns = not significant, ***p < 0.001. 
 
Figure 8: S-acylation of EGFP-SNAP25B by zDHHC3 TMD3 mutants. 
HEK293T cells were transfected with EGFP-SNAP25B and pEF-BOS-HA (vector) or the indicated wild-type or mutant zDHHC 
constructs. Cells were then incubated with C14:0, C16:0 or C18:0 fatty acid azides for 4h at 37 ºC. Fatty acid azides were labelled by 
click chemistry using an alkyne-800 infrared dye. Isolated proteins were resolved by SDS-PAGE and transferred to nitrocellulose 
membranes. (a) Sequence alignment of amino acids in the third transmembrane domain of zDHHC3 and zDHHC7; the blue boxes 
highlight Isoleucine-182 in zDHHC3 and Serine-185 in zDHHC7. (b) and (c) Analysis of EGFP-SNAP25B S-acylation by zDHHC3 TMD3 
mutants with fatty acid-azides. Representative images are shown on the left, graphs showing mean ± SEM are on the right. (b) n ≥ 6. 
(c) n ≥ 8. ns = not significant, ***p < 0.001. 
 
Figure 9: Incorporation of [3H]palmitic and [3H]stearic acid into EGFP-SNAP25B by zDHHC3 and zDHHC7. 
HEK293T cells were transfected with pEGFPC2 or EGFP-SNAP25B together with pEF-BOS-HA (vector), HA-zDHHC3, HA-zDHHC7, or 
HA-zDHHC3(I182S). Cells were labelled with either [3H]palmitic acid (Left panel) or [3H]stearic acid (Right panel), lysed, and resolved 
by SDS-PAGE. Top panel: [3H] fatty acid incorporation. Upper middle panel: expression levels of EGFP-SNAP25B. Lower middle panel: 
zDHHC protein expression. Molecular weight markers are shown on the left. Lower panel: Quantification of [3H]fatty acid 
incorporation normalised to EGFP-SNAP25B protein levels expressed as mean ± SEM. n = 3, ns = not significant. **p < 0.01; ***p < 
0.001. 
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